Qing-lei L. Zeng

No. 1, Eastern Jianshe Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Effect of water intake on routine laboratory test parameters in healthy adults: a cross-sectional study.

Effect of water intake on routine laboratory test parameters in healthy adults: a cross-sectional study.

Journal: Frontiers in medicine

Published: May 18, 2026

Histopathological features and eight-week split-tablet sofosbuvir/velpatasvir treatment in young children with acute hepatitis C: a case-series study.

Histopathological features and eight-week split-tablet sofosbuvir/velpatasvir treatment in young children with acute hepatitis C: a case-series study.

Journal: BMC infectious diseases

Published: November 17, 2025

Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes.

Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes.

Journal: Gut

Published: November 06, 2025

Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Impact of Chronic Hepatitis B and Its Clinical Phases on Liver Fibrosis and Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 08, 2025

Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report.

Functional cure in an occult hepatitis B virus infection patient on sequential therapy: A case report.

Journal: World journal of hepatology

Published: May 08, 2025

GNLY+CD8+ T cells bridge premature aging and persistent inflammation in people living with HIV.

GNLY+CD8+ T cells bridge premature aging and persistent inflammation in people living with HIV.

Journal: Emerging microbes & infections

Published: March 26, 2025

Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B.

Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B.

Journal: The New England journal of medicine

Published: February 26, 2025

Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis.

Type 2 diabetes mellitus as an independent predictor of significant fibrosis in treatment-naïve chronic hepatitis B patients with concurrent hepatic steatosis.

Journal: Hepatology (Baltimore, Md.)

Published: February 04, 2025

Comparative therapeutic efficacy of tenofovir amibufenamide versus tenofovir alafenamide in the treatment of patients with chronic hepatitis B: a real-world single- center study

Comparative therapeutic efficacy of tenofovir amibufenamide versus tenofovir alafenamide in the treatment of patients with chronic hepatitis B: a real-world single- center study

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: December 03, 2024

Expected 8-Week Prenatal vs 12-Week Perinatal Tenofovir Alafenamide Prophylaxis to Prevent Mother-to-Child Transmission of Hepatitis B Virus: A Multicenter, Prospective, Open-Label, Randomized Controlled Trial.

Expected 8-Week Prenatal vs 12-Week Perinatal Tenofovir Alafenamide Prophylaxis to Prevent Mother-to-Child Transmission of Hepatitis B Virus: A Multicenter, Prospective, Open-Label, Randomized Controlled Trial.

Journal: The American journal of gastroenterology

Published: August 20, 2024

Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China.

Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China.

Journal: BMJ open

Published: July 11, 2024

Curing of chronic hepatitis C combined with coronavirus disease 2019 in a couple over 85 years old: a case series study.

Curing of chronic hepatitis C combined with coronavirus disease 2019 in a couple over 85 years old: a case series study.

Journal: Frontiers in microbiology

Published: May 27, 2024

Showing 1-12 of 67

Last Updated: 09/26/2026